Paid Clinical Trials in Hagerstown, MD
As of June 2026, 39 paid clinical trials are recruiting in Hagerstown, Maryland. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Hagerstown offers studies at sites including Cumberland Valley Retina Consultants for conditions such as Geographic Atrophy, Macular Degeneration, Diabetic Macular Edema, Psoriatic Arthritis. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Hagerstown
Filter results
39 clinical trials
↓ Download CSVA Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
A Study to Evaluate the Efficacy and Safety of OTX-TKI (Axitinib Implant) in Participants With Non-Proliferative Diabetic Retinopathy
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO
Brief Motivational Interviewing +/- Mindfulness Training for Adolescent Alcohol Use in Pediatric Primary Care
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure
A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular Edema
Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
IDEAL: Efficacy of Porcine Placental Extracellular Matrix Augmented Plus Standard of Care (SOC) Versus SOC Alone for the Management of Diabetic Foot Ulcers
A Study to Evaluate the Efficacy and Safety of Orally Administered VX-01
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced and Biologic-naive Participants With Active Psoriatic Arthritis
A Safety and Efficacy Study of One-time SAR402663 in Adults With Neovascular Age-related Macular Degeneration
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)
Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy
Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
ConsideRAte Study - Splenic Stimulation for RA
A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus
Secukinumab Open Label Roll-over Extension Protocol
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
About research studies in Hagerstown
Hagerstown has approximately 39 recruiting research studies across a wide range of therapeutic areas. Maryland hosts Johns Hopkins Medicine and the NIH Clinical Center in Bethesda, giving participants access to some of the most advanced early-phase research in the country.
Top Research Study Locations in Hagerstown
Researchers run research studies in Hagerstown, MD at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Cumberland Valley Retina Consultants | Diabetic Macular Edema, Macular Edema Secondary to Inflammation, DME | 13 |
| Cumberland Valley Retina Consultants,P.C. | Geographic Atrophy, Macular Degeneration | 2 |
| Klein & Associates, M.D., P.A. | Psoriatic Arthritis, Overweight or Obesity | 2 |
| Mid Atlantic Retina Specialist | Age-related Macular Degeneration (AMD), Geographic Atrophy (GA), Neovascular Age-Related Macular Degeneration (nAMD) | 2 |
| Mid Atlantic Retina Specialists | Age-Related Macular Degeneration, Choroidal Neovascularization, Geographic Atrophy | 2 |
| Klein And Associates | Psoriatic Arthritis, Autoimmunity, Inflammation | 2 |
| ADARx Clinical Site | Geographic Atrophy Secondary to Age-related Macular Degeneration | 1 |
| Adverum Clinical | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 1 |
| Cumberland Valley Retina Consultants (CVRC) | Geographic Atrophy Secondary to Age-related Macular Degeneration | 1 |
| Cumberland Valley Retina Consultants - Hagerstown | Geographic Atrophy | 1 |
| Cumberland Valley Retina Consultants PC | Neovascular Age-related Macular Degeneration | 1 |
| Cumberland Valley Retina Consultants-Ophthalmology | Age-related Macular Degeneration (AMD), Geographic Atrophy (GA) | 1 |
| Hagerstown, MD | Branch Retinal Vein Occlusion (BRVO), Neovascular Age-Related Macular Degeneration (NVAMD) | 1 |
| Hagerstown, Maryland | Branch Retinal Vein Occlusion (BRVO), Neovascular Age-Related Macular Degeneration (NVAMD) | 1 |
| Johns Hopkins Community Physicians, Hagerstown | Adolescent Alcohol Use | 1 |
| Johns Hopkins University Comstock Center | Heart Failure, Obesity, Type2diabetes | 1 |
| Klein And Associates M D P A | Arthritis, Psoriatic | 1 |
| Maryland Vision Institute | Cataract | 1 |
| Meritus Center for Clinical Research | Breast Cancer | 1 |
| Mid Atlantic Retina Specialists - Hagerstown | DME, Diabetic Macular Edema, Diabetic Macular Edema (DME) | 1 |
| Mid Atlantic Retina Specialists - Hagerstown | AMD, CNV, Wet Age-related Macular Degeneration | 1 |
| National Spine and Pain Centers | Lumbar Spinal Stenosis | 1 |
| Parkway Surgery Center | Lumbar Spinal Stenosis | 1 |
| Sl0046 50015 | Systemic Lupus Erythematosus | 1 |
| The Osteoporosis & Clinical Trials Center | Rheumatoid Arthritis | 1 |
Active & Upcoming Studies in Hagerstown (2026)
Recruiting trials in Hagerstown grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Eye & vision (21 active studies)
- A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated · Phase 1, Phase 2 · Boehringer Ingelheim
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) · Phase 2, Phase 3 · EyeBiotech Ltd.
Diabetes & metabolic (2 active studies)
- Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure · Johns Hopkins University
- A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA) · Phase 4 · Eli Lilly and Company
Cancer & tumors (1 active study)
- EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD) · Exact Sciences Corporation
Cardiovascular (1 active study)
- Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure · Johns Hopkins University
Pediatric (1 active study)
Common conditions studied in Hagerstown
- Geographic Atrophy (4 active studies). Recruiting Geographic Atrophy studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Macular Degeneration (4 active studies). Recruiting Macular Degeneration studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Diabetic Macular Edema (3 active studies). Recruiting Diabetic Macular Edema studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Psoriatic Arthritis (3 active studies). Recruiting Psoriatic Arthritis studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Age-Related Macular Degeneration (2 active studies). Recruiting Age-Related Macular Degeneration studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Choroidal Neovascularization (2 active studies). Recruiting Choroidal Neovascularization studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Hagerstown
- AbbVie
- EyeBiotech Ltd.
- 4D Molecular Therapeutics
- Boehringer Ingelheim
- EyePoint Pharmaceuticals, Inc.
Local regulations and guidelines
Clinical trials in Maryland are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Maryland research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Hagerstown. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Hagerstown
Hipa.ai aggregates every recruiting study in Hagerstown from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Hagerstown?
There are approximately 39 recruiting clinical trials in Hagerstown, Maryland listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Hagerstown pay participants?
Most recruiting trials in Hagerstown compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Hagerstown?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Hagerstown?
The most common conditions under active study in Hagerstown include Geographic Atrophy (4), Macular Degeneration (4), Diabetic Macular Edema (3), Psoriatic Arthritis (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Hagerstown?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Hagerstown on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Hagerstown?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Hagerstown?
Recruiting research sites in Hagerstown include Cumberland Valley Retina Consultants, Cumberland Valley Retina Consultants,P.C., Klein & Associates, M.D., P.A., among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Hagerstown right now?
The largest active categories in Hagerstown are Eye & vision (21), Diabetes & metabolic (2), Cancer & tumors (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.